Health Catalyst (HCAT) Tops Q2 EPS by 6c

Health Catalyst (NASDAQ: HCAT) reported Q2 EPS of $0.05, $0.06 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $73.2 million versus the consensus estimate of $72.64 million.

For earnings history and earnings-related data on Health Catalyst (HCAT) click here.

You May Also Be Interested In

• Burry doubles down on Nebius short after stock surges 34% on earnings
• Ackman adds Netflix, Visa and Mastercard in portfolio revamp
• Rekor Systems, Inc. (REKR) Tops Q2 EPS by 3c